Imamura Tsuyoshi, Doi Yasufumi, Arima Hisatomi, Yonemoto Koji, Hata Jun, Kubo Michiaki, Tanizaki Yumihiro, Ibayashi Setsuro, Iida Mitsuo, Kiyohara Yutaka
Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Stroke. 2009 Feb;40(2):382-8. doi: 10.1161/STROKEAHA.108.529537. Epub 2008 Dec 18.
Although the relation between serum LDL cholesterol level and coronary heart disease (CHD) is well established, its relation with stroke subtypes is less clear.
A total of 2351 inhabitants age >or=40 years in a Japanese community were followed up for 19 years.
During follow-up, 271 subjects developed stroke and 144 developed CHD. Whereas the age- and sex-adjusted incidences of CHD significantly increased with increasing LDL cholesterol levels (P for trend <0.001), the associations between LDL cholesterol level and the incidences of ischemic or hemorrhagic stroke were not significant. The age- and sex-adjusted incidences of atherothrombotic infarctions (ATIs) and lacunar infarctions (LIs) significantly increased with increasing LDL cholesterol level (P for trend=0.03 for ATIs and=0.02 for LIs), but no such association was observed for cardioembolic infarction. After multivariate adjustment, the positive associations of LDL cholesterol level with the risks of ATI and CHD remained significant (P for trend=0.02 for ATIs and=0.03 for CHD), whereas the association with LIs was not significant. The risk of ATI significantly increased in the fourth quartile of LDL cholesterol compared with the first quartile (multivariate-adjusted hazard ratio=2.84; 95% CI, 1.17 to 6.93). The multivariate-adjusted risks for developing nonembolic infarction (ATIs and LIs) and CHD were significantly elevated in the groups with elevated LDL cholesterol values with and without the metabolic syndrome.
Our findings suggest that an elevated LDL cholesterol level is a significant risk factor for developing ATI as well as CHD, and these associations are independent of the metabolic syndrome.
虽然血清低密度脂蛋白胆固醇(LDL-C)水平与冠心病(CHD)之间的关系已得到充分证实,但其与卒中亚型的关系尚不清楚。
对日本某社区2351名年龄≥40岁的居民进行了19年的随访。
随访期间,271名受试者发生卒中,144名发生冠心病。校正年龄和性别后,冠心病的发病率随LDL-C水平升高而显著增加(趋势P<0.001),而LDL-C水平与缺血性或出血性卒中发病率之间的关联不显著。校正年龄和性别后,动脉粥样硬化血栓形成性梗死(ATI)和腔隙性梗死(LI)的发病率随LDL-C水平升高而显著增加(ATI趋势P=0.03,LI趋势P=0.02),但未观察到心源性脑栓塞梗死有此类关联。多因素校正后,LDL-C水平与ATI和冠心病风险的正相关关系仍然显著(ATI趋势P=0.02,冠心病趋势P=0.03),而与LI的关联不显著。与第一四分位数相比,LDL-C第四四分位数时ATI风险显著增加(多因素校正风险比=2.84;95%CI,1.17至6.93)。在有和没有代谢综合征的LDL-C值升高组中,发生非栓塞性梗死(ATI和LI)和冠心病的多因素校正风险显著升高。
我们的研究结果表明,LDL-C水平升高是发生ATI和冠心病的重要危险因素,且这些关联独立于代谢综合征。